NasdaqCM - Delayed Quote USD

NeuroOne Medical Technologies Corporation (NMTC)

0.8790 +0.0179 (+2.08%)

At close: November 6 at 4:00:01 PM EST

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

NeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial Pain

GlobeNewswire 12d ago

NMTC
+1.06%
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program

GlobeNewswire 17d ago

NMTC
+1.06%
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology

GlobeNewswire 1mo ago

NMTC
+1.06%
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

GlobeNewswire 1mo ago

NMTC
+1.06%
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform

NewMediaWire 2mo ago

NMTC
+1.06%
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time

NewMediaWire 3mo ago

NMTC
+1.06%
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians

NewMediaWire 3mo ago

NMTC
+1.06%
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial

NewMediaWire 3mo ago

NMTC
+1.06%
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NewMediaWire 4mo ago

NMTC
+1.06%
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index

NewMediaWire 4mo ago

NMTC
+1.06%
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time

NewMediaWire 4mo ago

NMTC
+1.06%
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026

NewMediaWire 5mo ago

NMTC
+1.06%

Performance Overview

Return	NMTC	S&P 500 (^GSPC)
YTD	-80.67%	+7.76%
1-Year	-79.62%	+9.77%
3-Year	-84.09%	+68.96%

U.S. markets closed

NeuroOne Medical Technologies Corporation (NMTC)

NeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial Pain

NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program

NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology

NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order

NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform

NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time

NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians

NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial

NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index

NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time

NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026